| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $19.3M | -59.1% |
| SG&A Expense | $13.0M | -18.4% |
| Operating Income | -$33.0M | +47.7% |
| Income Tax | $0 | — |
| Net Income | -$32.3M | +48.3% |
| EPS (Basic) | -$30.82 | -1085.4% |
| EPS (Diluted) | -$30.82 | -1085.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | -90.8% |
| Current Assets | $5.4M | -85.5% |
| Total Assets | $8.6M | -80.0% |
| Current Liabilities | $5.1M | -50.8% |
| Long-term Debt | $0 | — |
| Total Liabilities | $5.1M | -52.7% |
| Stockholders' Equity | $3.5M | -89.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.4M | +38.6% |
| Capital Expenditures | $49K | -96.1% |
| Investing Cash Flow | -$44K | -100.1% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$31.5M | +40.0% |